News

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has today become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.

Almost nine out of ten (87%) University of Cambridge submissions for the UK’s Research Excellence Framework (REF) have been rated as ‘world leading’ or ‘internationally excellent’, demonstrating the institution’s strength in research, figures released today show.

Some of Britain’s traditional Christmas favourites are losing their appeal, a new study of spoken English has revealed.

Forthcoming events

Vilnius Cathedral Square during Christmas
Saturday, 27 December 2014 - 7.00pm to 10.00pm EET

Join fellow Oxonians and Cantabridgians in Lithuania for their annual dinner event in the capital.

CUWBC crew
Wednesday, 14 January 2015 - 6.30pm to 8.30pm GMT

Join CUWBC to be inspired by leading women in the world of business, industry, sport and life at a new speaker series.

Industrie-Club, Dusseldorf
Friday, 23 January 2015 - 6.30pm CET

Join alumni in the Rheinland region of Germany for the 2015 Oxford, Cambridge and LSE New Year alumni Reception in Dusseldorf.

Alumni Groups

There nearly 450 volunteer-led Alumni Groups across the world.

Travel

Fascinating destinations, congenial companions and expert insights. Visit the travel page to find out more.